James Dignam to Tumor Suppressor Proteins
This is a "connection" page, showing publications James Dignam has written about Tumor Suppressor Proteins.
Connection Strength
0.224
-
Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial. J Clin Oncol. 2025 Sep 20; 43(27):3032-3040.
Score: 0.200
-
Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525. Neuro Oncol. 2015 Jul; 17(7):999-1006.
Score: 0.024